Clarametyx Biosciences

Clarametyx Biosciences is a late preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms.

Clarametyx Biosciences headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $5.7B in funding across 96 round(s). With a team of 11-50 employees, Clarametyx Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Clarametyx Biosciences, raised $5.0M. Discover more about their projects, partnerships, and impact on our platform.